Hospitals

What are my FMD obligations as a hospital?

Hospitals and other healthcare institutions are obliged to verify the authenticity of medicines with safety features and decommission them before they are supplied to patients.  This is done by checking that the anti-tamper device on the pack is intact and by scanning the 2D barcode on the pack and ‘decommissioning’ the pack via an Internet connection to the Irish Medicines Verification System. The scanning operation may take place any time after the medicines arrives in the hospital and the anti-tamper device check must be carried out at the time that the pack is supplied to a patient.

A key difference in FMD requirements between hospitals and community pharmacies is that verification and decommissioning of packs may take place between the pack being received in the hospital and being supplied to a patient. These means that decommissioning may take place at Goods Inwards in the pharmacy.

Certain medicinal products that carry safety features may be under the control of departments other than the hospital pharmacy, e.g. blood products managed by the hospital laboratory, fluids managed by Stores. It is important to ensure that arrangements are in place to ensure that these products are verified and decommissioned.

HSE hospitals and clinics

Implementation of FMD is managed centrally within the HSE.

If you are working in a HSE hospital or clinic and have any queries about getting connected to the IMVS or any aspect of FMD implementation in the health services, please email fmd.support@hse.ie.

Private hospitals, clinics and other healthcare institutions

Private hospitals, clinics and other healthcare institutions that need to register with IMVO and connect to the IMVS should follow the same process as for community pharmacies.

Getting connected to the IMVS

You can find more information about getting connected to the IMVS here.

Alert investigation

When you scan the 2D barcode, an alert will be generated if the data in the barcode or the pack status (‘active’/’decommissioned’) doesn’t match what’s in the IMVS. During the use and learn period, you may continue to supply the pack if an alert has been generated unless you have an overriding concern that the pack may be falsified or has been tampered with.

IMVO may contact you from time to time for additional information on alerts generated in your pharmacy. If you have any queries about alerts for IMVO, please email alert.support@imvo.ie or phone us on +353-1-5715320.

Use and learn

The Safety Features Oversight Group comprising the IMVO, the Department of Health, the Health Products Regulatory Authority (HPRA), the Pharmaceutical Society of Ireland (PSI), the Health Service Executive (HSE) and the Private Hospitals Association (PHA) has been closely monitoring progress with the implementation of the IMVS since it went live on 9th February 2019. In order to allow time for it to stabilise, the system has been in a use and learn phase since then and this will be ended on a phased basis over the coming months.  

During the use and learn period:

  1. All medicinal products released for the Irish market since 9th February 2019 must bear the safety features as required i.e. a tamper proof seal (anti-tamper device) and 2D barcode.
  2. During the use and learn period, pharmacies, hospitals and wholesalers must scan packs where obliged to do so and if an alert or any other unexpected message is flagged, should continue to supply packs to patients in accordance with their existing procedures, unless they have overriding concerns that a falsified medicine is involved.
  3. All alerts generated in pharmacies, wholesalers and hospitals, upon scanning a pack during the use and learn phase, are forwarded by the system to IMVO, the HPRA and the manufacturers/MAHs so that they can be investigated and monitored. 
  4. Notwithstanding the above, if a pharmacist or wholesaler has reason to believe that packaging has been interfered with, based on their examination of the anti-tampering device on the pack, they must report their concern to the HPRA (as a suspected quality defect via the usual reporting mechanisms) and not supply the pack.

National legislation to support the implementation of the Delegated Regulation was introduced in February 2019. However, offences for breaches of the legislation will not be commenced until a later date, after use and learn ends.

For more information on Use and Learn visit the News and Events page.

Guidance

Scanning guidance

How to scan correctly   – This short video demonstrates how to scan FMD packs and provides useful tips for scanning.

Check your scanner – Use the ‘IMVO Check your scanner’  guidance to test if your scanner is set up correctly. As part of checking your scanner you will need to determine which mode your scanner is in. The ‘Check your scanner’ guidance will tell you how to do this. 

If you identify problems with your scanner after carrying out those tests, then proceed to the relevant ‘IMVO Fix your scanner’ guidance for your scanner make and mode. These documents should help you fix any problems with your scanner and set it up correctly.

Fix your scanner – If you identify problems with your scanner after checking it, then you need to ‘fix’ them.  This is done by scanning a series of barcodes that will set your scanner to the correct configuration:

  1. The instructions for fixing the scanner depend on what make it is and the mode it is set up in (keyboard wedge or serial mode. Look at the scanner to see what make it is. See IMVO ‘Check Your Scanner’ for details of how to find out what mode it is in.
  2. IMVO has drawn up guidance on how to fix Datalogic and Honeywell scanners as these are the most commonly used FMD scanners in Ireland.
  3. If you have a Datalogic or Honeywell scanner, follow the instructions in the relevant ‘Fix Your Scanner’ guidance below. There are 4 different versions so use the one that corresponds to your scanner’s make and mode.
  4. If you are using any other make of scanner, your FMD software provider may be able to advise you on how to reconfigure it. Please also inform IMVO (Contact us) so that we can update our scanner guidance.
  5. If you’re unsure what to do next, please contact us at info@imvo.ie, including the make of your scanner in your email.

Datalogic Scanners

Honeywell Scanners

Guide to IMVS alerts and next steps

Information to follow

IMVO webinars for pharmacies & hospitals

For information on any upcoming webinars visit the News and Events page

PSI guidance

The PSI has a section on falsified medicines on its website with information for pharmacists.

Where to get support

Click here to find support information.

Useful Information

Click here to find useful information.